| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Elazzouzi Amy | Senior Vice President, Finance | C/O AURA BIOSCIENCES, INC., 80 GUEST STREET, BOSTON | /s/ Amy Elazzouzi | 18 Aug 2025 | 0002042910 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AURA | Common Stock | Options Exercise | $12,949 | +2,554 | +3.1% | $5.07 | 83,935 | 18 Aug 2025 | Direct | F1 |
| transaction | AURA | Common Stock | Options Exercise | $5,995 | +1,094 | +1.3% | $5.48 | 85,029 | 18 Aug 2025 | Direct | F1 |
| transaction | AURA | Common Stock | Options Exercise | $2,998 | +547 | +0.64% | $5.48 | 85,576 | 18 Aug 2025 | Direct | F1 |
| transaction | AURA | Common Stock | Options Exercise | $2,850 | +547 | +0.64% | $5.21 | 86,123 | 18 Aug 2025 | Direct | F1 |
| transaction | AURA | Common Stock | Options Exercise | $12,999 | +4,744 | +5.5% | $2.74 | 90,867 | 18 Aug 2025 | Direct | F1 |
| transaction | AURA | Common Stock | Options Exercise | $3,457 | +1,094 | +1.2% | $3.16 | 91,961 | 18 Aug 2025 | Direct | F1 |
| transaction | AURA | Common Stock | Options Exercise | $9,856 | +2,319 | +2.5% | $4.25 | 94,280 | 18 Aug 2025 | Direct | F1 |
| transaction | AURA | Common Stock | Sale | $51,737 | -7,722 | -8.2% | $6.70 | 86,558 | 18 Aug 2025 | Direct | F1, F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AURA | Stock Option (Right to Buy) | Options Exercise | $0 | -2,554 | -100% | $0.000000 | 0 | 18 Aug 2025 | Common Stock | 2,554 | $5.07 | Direct | F3 |
| transaction | AURA | Stock Option (Right to Buy) | Options Exercise | $0 | -1,094 | -100% | $0.000000 | 0 | 18 Aug 2025 | Common Stock | 1,094 | $5.48 | Direct | F3 |
| transaction | AURA | Stock Option (Right to Buy) | Options Exercise | $0 | -547 | -100% | $0.000000 | 0 | 18 Aug 2025 | Common Stock | 547 | $5.48 | Direct | F3 |
| transaction | AURA | Stock Option (Right to Buy) | Options Exercise | $0 | -547 | -100% | $0.000000 | 0 | 18 Aug 2025 | Common Stock | 547 | $5.21 | Direct | F3 |
| transaction | AURA | Stock Option (Right to Buy) | Options Exercise | $0 | -4,744 | -100% | $0.000000 | 0 | 18 Aug 2025 | Common Stock | 4,744 | $2.74 | Direct | F3 |
| transaction | AURA | Stock Option (Right to Buy) | Options Exercise | $0 | -1,094 | -100% | $0.000000 | 0 | 18 Aug 2025 | Common Stock | 1,094 | $3.16 | Direct | F3 |
| transaction | AURA | Stock Option (Right to Buy) | Options Exercise | $0 | -2,319 | -100% | $0.000000 | 0 | 18 Aug 2025 | Common Stock | 2,319 | $4.25 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | On August 18, 2025, the Reporting Person exercised long held stock options to purchase 12,899 shares of the Issuer's common stock, 7,722 of which were sold to cover the exercise price of such options. |
| F2 | The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.57 to $6.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F3 | This option is fully vested. |